Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Freezing of Gait in Parkinson's Disease
NCT03651856Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of atomoxetine in Parkinson's disease (PD), sponsored by Medical University of South Carolina. Primary endpoint: Number of Participants With Treatment Emergent Adverse Events at week 8. Started Jan 2013; status: completed.
02
Drugs
atomoxetine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03651856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651856.